Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival
Crossref DOI link: https://doi.org/10.1186/2193-1801-4-9
Published Online: 2015-01-13
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eremin, Jennifer
Cowley, Ged
Walker, Leslie G
Murray, Elisabeth
Stovickova, Monika
Eremin, Oleg
Text and Data Mining valid from 2015-01-13
Article History
Received: 16 December 2014
Accepted: 16 December 2014
First Online: 13 January 2015